These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25108533)

  • 41. Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales.
    Town K; Obi C; Quaye N; Chisholm S; Hughes G;
    Sex Transm Infect; 2017 Feb; 93(1):39-45. PubMed ID: 27382010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
    Unemo M; Golparian D; Oxelbark J; Kong FYS; Brown D; Louie A; Drusano G; Jacobsson S
    J Antimicrob Chemother; 2024 May; 79(5):1006-1013. PubMed ID: 38497988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
    Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
    N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. UK national guideline for the management of gonorrhoea in adults, 2011.
    Bignell C; Fitzgerald M; ;
    Int J STD AIDS; 2011 Oct; 22(10):541-7. PubMed ID: 21998172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin.
    Whiley DM; Jennison A; Pearson J; Lahra MM
    Lancet Infect Dis; 2018 Jul; 18(7):717-718. PubMed ID: 29976521
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea.
    Low N; Unemo M; Skov Jensen J; Breuer J; Stephenson JM
    PLoS Med; 2014 Feb; 11(2):e1001598. PubMed ID: 24503544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.
    Ohnishi M; Saika T; Hoshina S; Iwasaku K; Nakayama S; Watanabe H; Kitawaki J
    Emerg Infect Dis; 2011 Jan; 17(1):148-9. PubMed ID: 21192886
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
    Turner KM; Christensen H; Adams EJ; McAdams D; Fifer H; McDonnell A; Woodford N
    BMJ Open; 2017 Jun; 7(6):e015447. PubMed ID: 28615273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Testing for pharyngeal gonorrhoea in heterosexual men: should we revisit national guidelines?
    Dresser M; Hussey J
    Int J STD AIDS; 2020 May; 31(6):593-595. PubMed ID: 32295478
    [No Abstract]   [Full Text] [Related]  

  • 51. Should urologists care for the pharyngeal infection of Neisseria gonorrhoeae or Chlamydia trachomatis when we treat male urethritis?
    Hamasuna R; Takahashi S; Uehara S; Matsumoto T
    J Infect Chemother; 2012 Jun; 18(3):410-3. PubMed ID: 22302695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.
    Golparian D; Hellmark B; Fredlund H; Unemo M
    Sex Transm Infect; 2010 Nov; 86(6):454-60. PubMed ID: 20940159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone.
    Chisholm SA; Unemo M; Quaye N; Johansson E; Cole MJ; Ison CA; Van de Laar MJ
    Euro Surveill; 2013 Jan; 18(3):. PubMed ID: 23351652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?
    Jeverica S; Golparian D; Matičič M; Potočnik M; Mlakar B; Unemo M
    J Antimicrob Chemother; 2014 Jun; 69(6):1517-25. PubMed ID: 24535277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L;
    Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.
    Yasuda M; Hatazaki K; Ito S; Kitanohara M; Yoh M; Kojima M; Narita H; Kido A; Miyata K; Deguch T
    Sex Transm Dis; 2017 Mar; 44(3):149-153. PubMed ID: 28178112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis.
    Matsumoto T; Muratani T; Takahashi K; Ando Y; Sato Y; Kurashima M; Yokoo D; Ikuyama T; Shimokawa H; Yanai S
    J Infect Chemother; 2006 Apr; 12(2):97-9. PubMed ID: 16648949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Manavi K; Young H; McMillan A
    Int J STD AIDS; 2005 Jan; 16(1):68-70. PubMed ID: 15705277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany.
    Horn NN; Kresken M; Körber-Irrgang B; Göttig S; Wichelhaus C; Wichelhaus TA;
    Int J Med Microbiol; 2014 Jul; 304(5-6):586-91. PubMed ID: 24801146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection and analysis of two cases of the internationally spreading ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China.
    Yang F; Zhang H; Chen Y; Zhai Y; Zhao F; Yu Y; van der Veen S
    J Antimicrob Chemother; 2019 Dec; 74(12):3635-3636. PubMed ID: 31504585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.